| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/22/2008 | US7361719 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | CA2448864C Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 04/22/2008 | CA2270777C Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 04/17/2008 | WO2008046003A2 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 04/17/2008 | WO2008044243A2 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 04/17/2008 | WO2008044045A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008043839A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 04/17/2008 | WO2008043726A1 Sitamaquine tosylate for the treatment of leishmaniasis |
| 04/17/2008 | WO2008021491A3 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones |
| 04/17/2008 | US20080091028 selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; pain |
| 04/17/2008 | US20080090865 Non-insulin dependent diabetes; agonists of G-protein coupled receptor 40 (GPR40); for example, 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline |
| 04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090856 useful for the modulation of kinase activity of C-Abl, c-Kit, VEGFR, PDGFR, Flt-3, c-MET, HER family, Raf kinase family and disease polymorphs thereof; hyperproliferative diseases, cancer; 1-(5-(4-(1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorophenyl)-3-(3-isopropyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)urea |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
| 04/17/2008 | CA2672920A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatric disorders |
| 04/16/2008 | EP1911762A1 Amino alcohols and their use as renin inhibitors |
| 04/16/2008 | EP1911751A1 Amide derivative and pesticide containing such compound |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1910378A1 Hepatitis c inhibitor peptide analogs |
| 04/16/2008 | EP1910347A2 Macrocylic inhibitors of hepatitis c virus |
| 04/16/2008 | EP1910296A2 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 04/16/2008 | EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 04/16/2008 | EP1910272A1 Renin inhibitors |
| 04/16/2008 | EP1578727B1 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101161643A Production technique of 8-hydroxyquinoline |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | US7358398 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358259 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/10/2008 | WO2008041914A1 5-(2-AMINO-L-HYDROXYETHYL)-8-HYDROXY-2-OXOQUINOLINE DERIVATIVES AND OTHER COMPOUNDS AS β2 -ADRENERGIC AGONISTS |
| 04/10/2008 | WO2008041088A2 N-hydroxy benzamides with antitumor activity |
| 04/10/2008 | WO2008009970A3 Process for the preparation of montelukast |
| 04/10/2008 | WO2008003702A3 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/10/2008 | WO2007146824A3 Quinoline compounds and methods of use |
| 04/10/2008 | WO2007132482A3 Novel process for the preparation of pitavastatin and its pharmaceutically acceptable salts |
| 04/10/2008 | WO2007019180A3 Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof |
| 04/10/2008 | US20080086005 Novel crystalline forms of aripiprazole |
| 04/10/2008 | US20080085903 Novel crystalline forms of aripiprazole |
| 04/10/2008 | US20080085901 Heteroaryl Substituted Quinolin-4-Ylamine Analogues |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/09/2008 | EP1908753A1 Novel heterocyclidene acetamide derivative |
| 04/09/2008 | EP1908752A1 Novel 2-quinolone derivative |
| 04/09/2008 | EP1907364A1 Aripiprazole salts |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | CN101158680A Synthetic method of carbostyrile kind antibiotic multi cluster antigen |
| 04/08/2008 | US7355047 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 04/08/2008 | US7354931 Treating obstructive airway disorders using nontoxic drug |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008039642A2 Methods and compounds for treatment of clostridium based infection |
| 04/03/2008 | WO2008039641A2 Substituted phenylether-thienopyridone compounds with antibacterial activity |
| 04/03/2008 | WO2008039640A2 Enantiomeric compounds with antibacterial activity |
| 04/03/2008 | WO2008039639A2 Substituted thienopyridone compounds with antibacterial activity |
| 04/03/2008 | WO2008037784A1 Quinolinone derivatives |
| 04/03/2008 | WO2008037626A1 Quinoline derivatives with 5-ht-binding properties |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2007135565A3 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | WO2007125547A3 Novel process for statins and its pharmaceutically acceptable salts thereof |
| 04/03/2008 | WO2007070359A3 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 04/03/2008 | US20080081907 5-HT5A serotonin receptor activity; such as (5-Methyl-furan-2-ylmethyl)-(5-phenoxymethyl-quinolin-2-yl)-amine; anxiety, depression, sleep disorders, schizophrenia |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080079356 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | CA2664031A1 Quinoline derivatives with 5-ht-binding properties |
| 04/03/2008 | CA2660377A1 Quinolinone derivatives |
| 04/02/2008 | EP1904448A1 Purification of montelukast |
| 04/02/2008 | EP1904443A1 New benzoheterocyclylethylbenzamide derivatives |
| 04/02/2008 | EP1802581B1 4 [(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 04/02/2008 | EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides |
| 04/02/2008 | CN100378081C Process for the manufacture of organic compounds |
| 04/02/2008 | CN100378077C Process for producing quinolinecarbaldehyde |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CA2561987A1 Process for the preparation of highly pure hydroxychloroquine or a salt thereof |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 03/27/2008 | WO2008035379A2 Process for and intermediates of leukotriene antagonists |
| 03/27/2008 | WO2008035086A2 Synthesis of leukotriene compounds |
| 03/27/2008 | WO2008034628A1 Aripiprazole hemifumarate and process for its preparation |
| 03/27/2008 | US20080076796 Methods and Compositions for the Treatment of Alcoholism and Alcohol Dependence |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080075692 prophylaxis of blood disorder such as sickle cell anemia, beta -thalassemia, neutropenia or thrombocytopenia, comprising administering carboxylic acids, that stimulates production of fetal hemoglobin, hematopoiesis, erythropoiesis, myelopoiesis and neutrophil production |
| 03/26/2008 | EP1903038A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators |
| 03/26/2008 | EP1902030A1 Substituted quinolones ii |
| 03/26/2008 | EP1902029A1 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
| 03/26/2008 | EP1901743A1 Quinoline derivatives as antibacterial agents |
| 03/26/2008 | EP1696924B1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/26/2008 | EP1633716A4 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |